News
Medicine by Design announces four new team projects
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects that will lead to advances in the understanding and treatment of cardiovascular and lung diseases, diabetes and neurological disorders.
Researchers from U of T, affiliated hospitals form research consortium to study risks and benefits of cannabis
The Toronto Cannabis and Cannabinoid Research Consortium (TC3) was launched Thursday at a conference of researchers, government officials, policy-makers and industry representatives. TC3 combines the research muscle of the university with a dozen academic hospitals. “There is a huge research engine at U of T,” said Ruth Ross, a professor and chair of the Faculty of Medicine’s pharmacology and toxicology department and a member of the TC3 steering committee.
Cannabis Innovation Summit to officially launch U of T-led research consortium
Researchers from UofT and its affiliated hospitals will meet this week at the Cannabis Innovation Summit to launch TC3 (Toronto Cannabis and Cannabinoid Research Consortium — a partnership focused on the health effects of cannabis and related compounds.